At a Glance
| 2-Fluorodeschloroketamine | 3-MeO-PCMo | |
|---|---|---|
| Class | Dissociatives | Dissociatives |
| Common Dose (oral) | 25–70 mg | 200–300 mg |
| Total Duration | 1.1–2.5 hrs | 3–5 hrs |
| Routes | insufflatedoral |
2-Fluorodeschloroketamine, a Dissociatives, and 3-MeO-PCMo, a Dissociatives, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Dissociativess, meaning they share a common pharmacological foundation. They share 33 documented effects in common, with 14 effects unique to 2-Fluorodeschloroketamine and 3 unique to 3-MeO-PCMo. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| 2-Fluorodeschloroketamine | 3-MeO-PCMo | |
|---|---|---|
| Class | Dissociatives | Dissociatives |
| Common Dose (oral) | 25–70 mg | 200–300 mg |
| Total Duration | 1.1–2.5 hrs | 3–5 hrs |
| Routes | insufflatedoral |
| Effects | 47 documented | 36 documented |
| Interaction | Caution | |
| Level | 2-Fluorodeschloroketamine | 3-MeO-PCMo |
|---|---|---|
| Threshold | 5 mg | 50 mg |
| Light | 10–25 mg | 100–200 mg |
| Common | 25–70 mg | 200–300 mg |
| Strong | 70–140 mg | 300–400 mg |
| Heavy | 140 mg | 400 mg |
| Level | Dose |
|---|---|
| Threshold | 5 mg |
| Light | 10–45 mg |
| Common | 45–100 mg |
| Strong | 100–175 mg |
| Heavy | 175 mg |
2-Fluorodeschloroketamine
3-MeO-PCMo
Compounding dissociative effects can cause confusion, mania, and loss of motor control